Researchers discovered that marine-based omega-3s are eight times more effective at inhibiting tumour development and growth.
"This study is the first to compare the cancer-fighting potency of plant- versus marine-derived omega-3s on breast tumour development," said Professor David Ma, from the University of Guelph in Canada.
"There is evidence that both omega-3s from plants and marine sources are protective against cancer and we wanted to determine which form is more effective," he said.
There are three types of omega-3 fatty acids: a-linolenic acid (ALA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
More From This Section
The study, published in the Journal of Nutritional Biochemistry, involved feeding the different types of omega-3s to mice with a highly aggressive form of human breast cancer called HER-2.
HER-2 affects 25 per cent of women and has a poor prognosis. Ma exposed the mice to either the plant-based or the marine-based omega-3s, beginning in utero.
"The mice were exposed to the different omega-3s even before tumours developed, which allowed us to compare how effective the fatty acids are at prevention," said Ma.
Ma found overall exposure to marine-based omega-3s reduced the size of the tumours by 60 to 70 per cent and the number of tumours by 30 per cent.
However, higher doses of the plant-based fatty acid were required to deliver the same impact as the marine-based omega-3s.
Omega-3s prevent and fight cancer by turning on genes associated with the immune system and blocking tumour growth pathways, said Ma.
"It seems EPA and DHA are more effective at this. In North America, we don't get enough omega-3s from seafood, so there lies an opportunity to improve our diet and help prevent the risk of breast cancer," he said.